Patent · US Active

N-sulfamoyl-piperidineamides for the treatment or inhibition of obesity and related conditions

US7772225B2 · kind B2 · utility

0Cited by

0References

18Claims

0Family size

Assignee

Solvay Pharmaceuticals, GmbH · US

Inventors

Jochen Antel · Annaberg-Buchholz, DE
Michael Firnges · Barsinghausen, DE
Uwe Schoen · Burgdorf, DE
Harald Waldeck · Hannover, DE
Michael Wurl · Garbsen, DE
Dania Birte REICHE · Bingen, DE
Peter-Colin Gregory · Hannover, DE

Key dates

Filing date	Dec 8, 2006
Grant date	Aug 10, 2010
Priority date	—
Expiry date	Jul 21, 2027

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D413/04
WIPO fieldOrganic fine chemistry
WIPO sectorChemistry

Abstract

The present invention relates to novel N-sulfamoyl-piperidineamides of Formula I and their physiologically acceptable acid addition salts, to pharmaceutical compositions comprising them, processes for their preparation, and their use for the treatment of obesity and its concomitant and/or secondary diseases and related or other conditions.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.